Scholar Rock Holding (SRRK) Current Leases (2018 - 2026)
Scholar Rock Holding's quarterly Current Leases came in at $6.1 million in Q1 2026, up 10.53% year-on-year from $5.5 million in Q1 2025, and up 9.48% quarter-over-quarter from $5.6 million in Q4 2025.
Scholar Rock Holding has reported Current Leases for 9 years, with the latest figure at $6.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 10.53% year-over-year to $6.1 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (up 10.53% YoY), and the FY2025 full-year result was $5.6 million, down 3.88% from the prior year.
- Current Leases for Q1 2026 stood at $6.1 million, up from $5.6 million in the prior quarter.
- The five-year high for Current Leases was $8.1 million in Q3 2022, with the low at $5.2 million in Q2 2025.
- Average Current Leases over 5 years is $6.7 million, with a median of $7.2 million recorded in 2023.
- Year-over-year, Current Leases surged 34.41% in 2022 and retreated 27.85% in 2025.
- Tracing SRRK's Current Leases over 5 years: stood at $7.9 million in 2022, then slipped by 5.65% to $7.4 million in 2023, then decreased by 22.06% to $5.8 million in 2024, then retreated by 3.88% to $5.6 million in 2025, then grew by 9.48% to $6.1 million in 2026.
- The last three Current Leases figures came in at $6.1 million (Q1 2026), $5.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 6.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.08 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 7.64 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 7.00 Mn |
| Mar 31, 2021 | 5.67 Mn |
| Dec 31, 2020 | 5.37 Mn |
| Sep 30, 2020 | 4.07 Mn |
| Jun 30, 2020 | 1.27 Mn |
| Mar 31, 2020 | 1.20 Mn |
| Dec 31, 2019 | 1.14 Mn |
| Sep 30, 2019 | 1.08 Mn |
| Jun 30, 2019 | 1.06 Mn |
| Mar 31, 2019 | 1.04 Mn |
| Sep 30, 2018 | 14,000.00 |